1.山东中医药大学第一临床医学院 济南 250014
2.山东中医药大学附属医院
魏秀楠,女,在读博士生
#迟莉丽,女,博士,主任医师,教授,博士生导师,主要研究方向:消化系统疾病的中西医基础与临床研究,E-mail:chililiyl@163.com
纸质出版日期:2024-10-30,
网络出版日期:2024-08-21,
收稿日期:2024-04-23,
移动端阅览
魏秀楠, 梁峻尉, 孙大娟, 等. 从“虚毒”探讨炎症性肠病“炎癌转化”[J]. 北京中医药大学学报, 2024,47(10):1349-1354.
WEI Xiunan, LIANG Junwei, SUN Dajuan, et al. Discussion on " inflammation-cancer transformation" of inflammatory bowel disease from the perspective of " deficiency-toxin" theory[J]. Journal of Beijing University of Traditional Chinese Medicine, 2024,47(10):1349-1354.
魏秀楠, 梁峻尉, 孙大娟, 等. 从“虚毒”探讨炎症性肠病“炎癌转化”[J]. 北京中医药大学学报, 2024,47(10):1349-1354. DOI: 10.3969/j.issn.1006-2157.2024.10.003.
WEI Xiunan, LIANG Junwei, SUN Dajuan, et al. Discussion on " inflammation-cancer transformation" of inflammatory bowel disease from the perspective of " deficiency-toxin" theory[J]. Journal of Beijing University of Traditional Chinese Medicine, 2024,47(10):1349-1354. DOI: 10.3969/j.issn.1006-2157.2024.10.003.
“虚”“毒”作为中医理论的重要概念,自《黄帝内经》以来不断丰富发展。本文通过追溯、梳理“虚”与“毒”,归纳二者关系,并结合临证实践,分析阐释其基本内涵,并探讨其外延。“虚毒”学说有静态与动态两层含义,既涵盖人体正气虚馁、邪毒亢盛的病理状态,又指代“虚”与“毒”相互推进的病理演变过程。基于“虚毒”学说的内涵及动态病机观点,该学说可适用于传染性疾病及虚损性疾病的防治,炎症性肠病“炎癌转化”亦在其列。本文以炎症性肠病为例,结合其西医学背景,阐述炎症性肠病“炎癌转化”的病机及治法,提供“虚毒”学说指导临床科研的范式。
As essential concepts of the traditional Chinese medicine theory
" deficiency" and " toxin" have been enriched and developed continuously since
Huangdi Neijing
. By tracing back and combing " deficiency" and " toxin"
this paper sums up their relationship
analyzes and explains their basic connotation
and discusses their extension. The " deficiency-toxin" theory has two meanings: it covers the pathological state of the human body with deficiency of vital qi and excess of pathogenic toxin
and it also refers to the pathological evolutionary process in which " deficiency" and " toxin" promote each other. Based on the connotation and dynamic pathogenesis of the " deficiency-toxin" theory
it is pointed out that this theory can be applied to the prevention and treatment of infectious diseases and chronic debilitating diseases
including the " inflammation-cancer transformation" of inflammatory bowel disease. Taking inflammatory bowel disease as an example and combining its Western medical background
this paper expounds on the pathogenesis and treatment of the " inflammation-cancer transformation" of inflammatory bowel disease
and provides a paradigm of " deficiency-toxin" theory guiding clinical research.
虚毒炎癌转化炎症性肠病
deficiency-toxininflammation-cancer transformationinflammatory bowel disease
程海波,李柳,沈卫星,等. 癌毒病机辨治体系的构建[J]. 南京中医药大学学报,2022, 38(7): 559-564.
李佃贵. 从浊毒理论的建立与应用谈中医学创新与发展[J]. 中医杂志,2020, 61(22): 1938-1940.
贺娟. 论《黄帝内经》之“虚邪”[J]. 北京中医药大学学报,2021, 44(1): 9-13.
任明名,顾立梅,杨文娟,等. 国医大师周仲瑛从湿热瘀毒、脾气亏虚论治结直肠癌经验[J]. 中华中医药杂志,2022, 37(8): 4488-4492.
曹璐畅,王新苗,朱广辉,等. 基于“阳虚毒结”论胃肠道肿瘤治阳五法[J]. 中国中医基础医学杂志,2022, 28(8): 1359-1362.
朱昱翎,白宇宁,姚乃礼. 从“脾虚络阻毒损”认识胃癌前病变胃黏膜屏障损伤及其辨治思路[J]. 中医杂志,2013, 54(10): 817-820.
朱超林,薛维伟,潘宇,等. 刘沈林教授胃癌“脾虚毒蕴”学说临床实践[J]. 世界科学技术—中医药现代化,2013, 15(5): 932-934.
刘晓明,张伟. 从毒、虚论述肺间质纤维化的病因病机[J]. 南京中医药大学学报,2014, 30(4): 306-308.
陈四清. 从阴虚毒瘀治疗肺结核[J]. 江苏中医药,2005, 26(3): 33.
衣秀秀,罗斌,钱芳芳,等. 从免疫抑制和循环肿瘤细胞探讨肺癌核心病机“正虚伏毒”的生物学基础[J]. 世界科学技术—中医药现代化,2019, 21(5): 963-969.
官杰,李浩,刘剑刚. 从中医虚毒病机论治老年性痴呆的研究与思考[J]. 中国中医药信息杂志,2012, 19(7): 104-106.
赵峻德,李淑玲,师伟,等. 李淑玲基于“本虚毒蕴”论治外阴白色病变经验浅梳[J]. 时珍国医国药,2022, 33(4): 976-978.
杨家熙,寇秋爱. 从“毒热致虚”理论探讨类风湿关节炎伴贫血辨治思路[J]. 中国实验方剂学杂志,2022, 28(20): 218-225.
陶雨晨,陆嘉惠,周永明,等. 骨髓增生异常综合征“虚毒并治”临床策略与科学实证[J]. 中华中医药杂志,2021, 36(10): 5988-5992.
许鸣,郭元成,任建业,等. “扶正”“祛邪”中药醇提物调控骨髓增生异常综合征细胞组蛋白乙酰化及TLR2表达诱导凋亡的体外研究[J]. 中华中医药学刊,2018, 36(9): 2098-2106.
童光东,王宇新,邢宇锋,等. 从“虚、毒、瘀、积”论慢性乙型肝炎及相关肝硬化、肝癌的治疗[J]. 中医杂志,2021, 62(16): 1404-1407.
张亚萍,林辰,李永亮,等. 从壮医“毒虚论”谈艾滋病的防治[J]. 中国中医基础医学杂志,2011, 17(6): 614-615.
周芷聿,师伟. 从“正虚毒聚”理论探讨HR-HPV感染的病机与治疗[J]. 中医药学报,2022, 50(10): 52-55.
CORREA P, HAENSZEL W, CUELLO C, et al. A model for gastric cancer epidemiology[J]. Lancet, 1975, 2(7924): 58-60.
SHAH SC, ITZKOWITZ SH. Colorectal cancer in inflammatory bowel disease: mechanisms and management[J]. Gastroenterology, 2022, 162(3): 715-730.
于晗. 巨噬细胞Gankyrin介导的炎症失调控在肝脏炎癌转化中的机理研究[D]. 上海:中国人民解放军海军军医大学,2022.
刘彧,吴琼蔚,张文璎,等. BRCC3/NLRP3促进子宫内膜异位症炎癌转化中的机制[J]. 中国肿瘤生物治疗杂志,2023, 30(1): 35-41.
ROGLER G. Chronic ulcerative colitis and colorectal cancer[J]. Cancer Lett, 2014, 345(2): 235-241.
CHOI CR, BAKIR IA, DING NJ, et al. Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study[J]. Gut, 2019, 68(3): 414-422.
梁峻尉,白文筠,王晓燕,等. 基于“虚毒”理论观察中西医结合疗法对脾虚湿蕴型溃疡性结肠炎活动期的临床疗效[J]. 时珍国医国药,2022, 33(4): 902-906.
迟莉丽,樊静娜,孙大娟,等. 安肠愈疡汤联合美沙拉秦对溃疡性结肠炎不同肠段内镜下及组织病理学表现的影响[J]. 山东中医杂志,2020, 39(9): 936-943.
孙大娟,魏秀楠,程艳,等. 黄芪-败酱草药对对HT-29细胞炎症模型JAK1/STAT6/SOCS1信号通路的影响[J]. 中医杂志,2023, 64(3): 295-302.
ACTIS GC, PELLICANO R, ROSINA F. Inflammatory bowel diseases: current problems and future tasks[J]. World J Gastrointest Pharmacol Ther, 2014, 5(3): 169-174.
MARTINI E, KRUG SM, SIEGMUND B, et al. Mend your fences: the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease[J]. Cell Mol Gastroenterol Hepatol, 2017, 4(1): 33-46.
PINETON DE CHAMBRUN G, BLANC P, PEYRIN-BIROULET L. Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease[J]. Expert Rev Gastroenterol Hepatol, 2016, 10(8): 915-927.
中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]. 中国实用内科杂志,2018, 38(9): 796-813.
MAGRO F, DOHERTY G, PEYRIN-BIROULET L, et al. ECCO position paper: harmonization of the approach to ulcerative colitis histopathology[J]. J Crohns Colitis, 2020, 14(11): 1503-1511.
窦婧,赵继亭,苗秀明,等. 解毒生化汤联合美沙拉秦肠溶片治疗溃疡性结肠炎的疗效及作用机制研究[J]. 山东中医杂志,2020, 39(6): 554-559.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构